|
|
||||||||
| ABSTRACT |
|
|
|---|
| INTRODUCTION |
|
|
|---|
Coxiella burnetii.3 Coxiella burnetii exists globally except for Antarctica and probably New Zealand.4 It infects arthropods of the class Arachnida including primarily ticks, and also reptiles and other vertebrates including humans, but causes natural disease predominantly only in humans. Domestic sheep, cattle, and goats are most commonly infected and often transmit the disease to humans by excretory products, milk, and hide but most effectively by parturient products. In 1949, an epidemiologic survey among domestic sheep in California indicated that 24% had microagglutinating antibodies to C. burnetii.5 More recent studies6,7 suggest that seroprevalence in these domestic ruminants is currently higher than it was 20 to 30 years ago. In most instances the diagnosis of Q fever is established serologically in humans as well as exposure in animals.4 There are several serologic methods that are used including complement fixation (CF), indirect immunofluorescence assay (IFA), and enzyme-linked immunosorbent fluorescence assay (ELISA). CF is quite specific but less sensitive than IFA and ELISA.4 C. burnetii exhibits an host-dependent antigenic variation termed phase variation 1 and 2 due to mutational changes in lipopolysaccharide profiles, which results in small-cell and large-cell variants; the former survives in the environment whereas the latter multiplies in the host monocyte or macrophage. Bacteria isolated directly from patients or laboratory animals are in phase 1 whereas those isolated after repeated passage through embryonated hens eggs are in phase 2. In an apparent paradox, antibodies to phase 2 antigen is associated with an acute illness and an antibody rise to phase 1 antigen occurs in chronic disease. In particular, the IgM antibody response to phase 2 antigen indicates an acute reaction, whereas repetitive replication in cell cultures results in poor antigenic stimulation and a less virulent organism resulting in a type 1 antibody of IgG and IgA subclasses and indicative of chronic infection.8 Impaired maturation of phagosomes and defective killing of C. burnetii appear to be responsible for the development of chronic Q fever9 and perhaps carriage of the organism and the absence of disease in ungulates.
Native American bighorn sheep (Ovis canadensis) have inhabited the United States for more than 25,000 years. Originally described by Lewis and Clark in 1804 the bighorn population was estimated to constitute more than 1 million animals ranging from the prairies in the mid-west to the mountains near the Pacific Ocean. Currently less than 75,000 bighorn inhabit the continental United States. Two subspecies currently exist in Southern California, Ovis canadensis cremnobates and O. canadensis nelsoni. The former were listed as an endangered species in 1998 and inhabit the San Jacinto and Santa Rosa mountains extending from eastern Riverside county in California to the Mexican border.
Peninsular bighorn sheep are unique in that they are low level sheep. Typically, other subspecies of bighorn range from 4,00010,000 feet elevation when given the choice, whereas peninsular bighorn access habitat from 4004,000 feet despite having access to mountains as high as 10,000 feet. Peninsular bighorn sheep are gregarious and usually spend time in groups of 210 bighorn, but may form larger groups, especially during the lambing season when ewes and lambs often congregate. There are 8 subgroups of Peninsular bighorn in the Peninsular ranges that are connected by ram movement. It is important to have connectivity to maintain herd health.
The Peninsular mountains surround the western limits of the Coachella and Imperial Valleys of the Colorado desert of Southern California, which has virtually no large scale animal husbandry in the area, However, for nearly 4 decades ranchers from Idaho, Wyoming, and Montana have imported their sheep to areas near Palm Springs and Blythe, California to graze and lamb during the fall and winter months. Occasional cases of Q fever have been seen at the Eisenhower Medical Center, a 265-bed general hospital that has also served as a referral facility to the area over the past 34 years. Most infections have been attributed to contact with these sheep often indirectly by living near or intruding into these sheep areas. Since the habitats of domestic and bighorn sheep are so strikingly different, we were interested in evaluating C. burnetii serologies of Peninsular bighorn sheep.
| MATERIALS AND METHODS |
|
|
|---|
| RESULTS |
|
|
|---|
Positive results were obtained in the years 19921999, and are divided as follows: 1992, 2/18 positive, 1:20(1), 1:80(1); 1993, 1/19 positive, 1:20(1); 1994,2/20 positive, 1:20(2); 1995, 2/21 positive, 1:20(2); 1996, 9/28 positive, 1:20(9); 1997, 5/7 positive, 1:20(5); 1998, 4/30 positive, 1:40(1), 1:20(3);1999, 2/30 positive, 1:20(2).
Since the Peninsular bighorn were listed as endangered in 1998, the Recovery Plan established guidelines and recommendations limiting livestock operations in the Peninsular ranges.10 These livestock restrictions may give us some understanding of the change of Q fever antibody testing in Peninsular bighorn since 1999.
| DISCUSSION |
|
|
|---|
The existence of C. burnetii infection in feral animals has been documented in kangaroos, wallabies, and wallaroos in Australia12 as well as deer in central Europe and Alaska1316 and marsupials and rodents in French Guiana.17 In Alaska complement fixing antibodies > 1:10 to C. burnetii are found in the sera of 12 of 18 Dall sheep16 suggesting that infection is widespread in Dall sheep of the Central Alaska Range. In California the seroprevalence in wildlife animals includes coyotes (78%), gray foxes (55%), skunks (21%), raccoons (8%), rabbits (53%), deer (22%), mice (22%), birds (20%), and bears (7%), In Idaho 6% of bears, and in Florida 10% of bears have Q-fever antibody whereas in Arkansas 80% of wild sheep possess antibodies to Coxiella burnetii.
We have not found any previous reports detailing exposure of bighorn sheep to C. burnetii in the United States. Our current serologic study of 268 peninsular sheep from Southern California indicates antibody to C. burnetii occurs in about 10% of animals. This prevalence is far less than has been reported from elsewhere where the infection exists in feral animals.
Implicit in this observation is that Q fever has not been a major factor in the decline in population of the Peninsular bighorn sheep. Indeed, pneumonia has been a prominent and major cause of lamb mortality but has been shown to be secondary to viral infection (usually parainfluena3) complicated by Pasteurella hemolytica superinfection.18 Our opinion is that the decline of peninsular bighorn sheep in Southern California results from loss of habitat due to human intrusion into bighorn habitat and not to infection. Supporting this conclusion is the recent observation that the number of bighorn sheep has increased by 100% since measures have been initiated to protect their habitat from human intrusion.
The absence of exposure to C. burnetii in Peninsular bighorn sheep but its high prevalence in imported domestic sheep into the Southern California desert certainly implies that their distant habitats exert a major influence on this observation. Furthermore it would also imply the natural absence of C. burnetii-infected arachnids in the remote areas of Southern California deserts and mountains appears to be due to the absence of animal husbandry in the area. When this does occur as with the importation of infected domestic sheep, human Q fever serves to identify habitat contamination.
In our study the CF test was used and although it is not as sensitive as the IFA and ELISA the blood was drawn within 3 months of lambing. In primary Q fever in humans, phase 2 antibody ordinarily persists at moderate titers for 3 months to 1 year.8 Thus, assuming a similar quantitative serologic response in mammals, it would appear that the interval of up to 3 months would accurately detect exposure to C. burnetii.
Received July 17, 2005. Accepted for publication April 18, 2006.
* Address correspondence to Lawrence A. Cone, Eisenhower Medical Center, Probst Professional Building, Suite 308, 39000 Bob Hope Drive, Rancho Mirage, CA 92270. E-mail: laconemedico{at}aol.com ![]()
Authors addresses: James R. Deforge, Bighorn Institute, P.O. Box 262, Palm Desert, CA 92261-0262, Telephone: 760-346-7334, Fax: 760-340-3987. Lawrence A. Cone, Eisenhower Medical Center, Probst Professional Building, Suite 308, 39000, Bob Hope Drive, Rancho Mirage, CA 92270. E-mail: laconemedico{at}aol.com.
| REFERENCES |
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |